349 related articles for article (PubMed ID: 11844733)
21. Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study.
Sastre-Garriga J; Ingle GT; Chard DT; Cercignani M; Ramió-Torrentà L; Miller DH; Thompson AJ
Brain; 2005 Jun; 128(Pt 6):1454-60. PubMed ID: 15817511
[TBL] [Abstract][Full Text] [Related]
22. Disability in multiple sclerosis is related to normal appearing brain tissue MTR histogram abnormalities.
Traboulsee A; Dehmeshki J; Peters KR; Griffin CM; Brex PA; Silver N; Ciccarrelli O; Chard DT; Barker GJ; Thompson AJ; Miller DH
Mult Scler; 2003 Dec; 9(6):566-73. PubMed ID: 14664468
[TBL] [Abstract][Full Text] [Related]
23. Loss of retinal nerve fibre layer axons indicates white but not grey matter damage in early multiple sclerosis.
Young KL; Brandt AU; Petzold A; Reitz LY; Lintze F; Paul F; Martin R; Schippling S
Eur J Neurol; 2013 May; 20(5):803-11. PubMed ID: 23369013
[TBL] [Abstract][Full Text] [Related]
24. The effect of gadolinium-enhancing lesions on whole brain atrophy in relapsing-remitting MS.
Saindane AM; Ge Y; Udupa JK; Babb JS; Mannon LJ; Grossman RI
Neurology; 2000 Jul; 55(1):61-5. PubMed ID: 10891907
[TBL] [Abstract][Full Text] [Related]
25. Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes.
Vidal-Jordana A; Sastre-Garriga J; Pérez-Miralles F; Tur C; Tintoré M; Horga A; Auger C; Río J; Nos C; Edo MC; Arévalo MJ; Castilló J; Rovira A; Montalban X
Mult Scler; 2013 Aug; 19(9):1175-81. PubMed ID: 23319072
[TBL] [Abstract][Full Text] [Related]
26. Brain atrophy in relapsing multiple sclerosis: relationship to relapses, EDSS, and treatment with interferon beta-1a.
Rudick RA; Fisher E; Lee JC; Duda JT; Simon J
Mult Scler; 2000 Dec; 6(6):365-72. PubMed ID: 11212130
[TBL] [Abstract][Full Text] [Related]
27. Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes.
Dalton CM; Chard DT; Davies GR; Miszkiel KA; Altmann DR; Fernando K; Plant GT; Thompson AJ; Miller DH
Brain; 2004 May; 127(Pt 5):1101-7. PubMed ID: 14998914
[TBL] [Abstract][Full Text] [Related]
28. Atrophy is detectable within a 3-month period in untreated patients with active relapsing remitting multiple sclerosis.
Hardmeier M; Wagenpfeil S; Freitag P; Fisher E; Rudick RA; Kooijmans-Coutinho M; Clanet M; Radue EW; Kappos L;
Arch Neurol; 2003 Dec; 60(12):1736-9. PubMed ID: 14676048
[TBL] [Abstract][Full Text] [Related]
29. Diffusely abnormal white matter converts to T2 lesion volume in the absence of MRI-detectable acute inflammation.
Dadar M; Mahmoud S; Narayanan S; Collins DL; Arnold DL; Maranzano J
Brain; 2022 Jun; 145(6):2008-2017. PubMed ID: 34927199
[TBL] [Abstract][Full Text] [Related]
30. Progression of regional grey matter atrophy in multiple sclerosis.
Eshaghi A; Marinescu RV; Young AL; Firth NC; Prados F; Jorge Cardoso M; Tur C; De Angelis F; Cawley N; Brownlee WJ; De Stefano N; Laura Stromillo M; Battaglini M; Ruggieri S; Gasperini C; Filippi M; Rocca MA; Rovira A; Sastre-Garriga J; Geurts JJG; Vrenken H; Wottschel V; Leurs CE; Uitdehaag B; Pirpamer L; Enzinger C; Ourselin S; Gandini Wheeler-Kingshott CA; Chard D; Thompson AJ; Barkhof F; Alexander DC; Ciccarelli O
Brain; 2018 Jun; 141(6):1665-1677. PubMed ID: 29741648
[TBL] [Abstract][Full Text] [Related]
31. Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis.
Sastre-Garriga J; Arévalo MJ; Renom M; Alonso J; González I; Galán I; Montalban X; Rovira A
J Neurol Sci; 2009 Jul; 282(1-2):120-4. PubMed ID: 19157420
[TBL] [Abstract][Full Text] [Related]
32. Cervical cord area is associated with infratentorial grey and white matter volume predominantly in relapsing-remitting multiple sclerosis: A study using semi-automated cord volumetry and voxel-based morphometry.
Bellenberg B; Schneider R; Weiler F; Suchan B; Haghikia A; Hoffjan S; Gold R; Köster O; Lukas C
Mult Scler Relat Disord; 2015 May; 4(3):264-72. PubMed ID: 26008944
[TBL] [Abstract][Full Text] [Related]
33. MRI characteristics of patients with antiphospholipid syndrome and multiple sclerosis.
Stosic M; Ambrus J; Garg N; Weinstock-Guttman B; Ramanathan M; Kalman B; Minagar A; Munschauer FE; Galey TM; Hussein S; Bakshi R; Zivadinov R
J Neurol; 2010 Jan; 257(1):63-71. PubMed ID: 19633967
[TBL] [Abstract][Full Text] [Related]
34. Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis.
Datta G; Colasanti A; Rabiner EA; Gunn RN; Malik O; Ciccarelli O; Nicholas R; Van Vlierberghe E; Van Hecke W; Searle G; Santos-Ribeiro A; Matthews PM
Brain; 2017 Nov; 140(11):2927-2938. PubMed ID: 29053775
[TBL] [Abstract][Full Text] [Related]
35. A voxel-based morphometry study of disease severity correlates in relapsing-- remitting multiple sclerosis.
Prinster A; Quarantelli M; Lanzillo R; Orefice G; Vacca G; Carotenuto B; Alfano B; Brunetti A; Morra VB; Salvatore M
Mult Scler; 2010 Jan; 16(1):45-54. PubMed ID: 20028706
[TBL] [Abstract][Full Text] [Related]
36. Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study.
Tedeschi G; Dinacci D; Comerci M; Lavorgna L; Savettieri G; Quattrone A; Livrea P; Patti F; Morra VB; Servillo G; Orefice G; Paciello M; Prinster A; Coniglio G; Bonavita S; Di Costanzo A; Bellacosa A; Valentino P; Quarantelli M; Brunetti A; Salemi G; D'Amelio M; Simone I; Salvatore M; Bonavita V; Alfano B
Mult Scler; 2009 Feb; 15(2):204-11. PubMed ID: 18987104
[TBL] [Abstract][Full Text] [Related]
37. Progression in disability and regional grey matter atrophy in relapsing-remitting multiple sclerosis.
Hofstetter L; Naegelin Y; Filli L; Kuster P; Traud S; Smieskova R; Mueller-Lenke N; Kappos L; Gass A; Sprenger T; Penner IK; Nichols TE; Vrenken H; Barkhof F; Polman C; Radue EW; Borgwardt SJ; Bendfeldt K
Mult Scler; 2014 Feb; 20(2):202-13. PubMed ID: 23804554
[TBL] [Abstract][Full Text] [Related]
38. Brain atrophy and physical disability in primary progressive multiple sclerosis: A volumetric study.
Galego O; Gouveia A; Batista S; Moura C; Machado E
Neuroradiol J; 2015 Jun; 28(3):354-8. PubMed ID: 26246109
[TBL] [Abstract][Full Text] [Related]
39. Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis.
Brass SD; Benedict RH; Weinstock-Guttman B; Munschauer F; Bakshi R
Mult Scler; 2006 Aug; 12(4):437-44. PubMed ID: 16900757
[TBL] [Abstract][Full Text] [Related]
40. Non-lesional white matter in relapsing-remitting multiple sclerosis assessed by multicomponent T2 relaxation.
Bontempi P; Rozzanigo U; Marangoni S; Fogazzi E; Ravanelli D; Cazzoletti L; Giometto B; Farace P
Brain Behav; 2023 Dec; 13(12):e3334. PubMed ID: 38041516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
